IP Library Granted Patent US 8,809,529
Granted Patent B2
US 8,809,529 · App. 13/287,992 · Granted Aug 19, 2014

Imidazo[1,2-α]pyrazine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,809,529
App. No.
13/287,992
Granted
Aug 19, 2014
Kind
B2
Abstract

The present invention provides, among other things, imidazo[1,2-α]pyrazine derivatives according for Formula (Ia) or Formula (Ib). The derivatives are useful in any method which other coelenterazines have been used. For example, the derivatives may be used in a bioluminogenic method to detect the presence of certain compounds or molecules.

Claims (78)

1. A compound of formula (Ia) or formula (Ib):

wherein R 2 is selected from the group consisting of

or C 2-5 straight chain alkyl;

R 6 is selected from the group consisting of —H, —OH, —NH 2 , —OC(O)R or —OCH 2 OC(O)R;

R 8 is selected from the group consisting of —CH 2 C 6 H 5 , H or lower cycloalkyl;

W is —NH 2 , halo, —OH, —NHC(O)R, —CO 2 R;

X is —S—, —O— or —NR 22 —;

Y is —H, —OH, or —OR 11 ;

Z is —CH— or —N—;

each R 11 is independently —C(O)R″ or —CH 2 OC(O)R″;

R 22 is H;

each R is independently C 1-7 straight-chain alkyl or C 3-7 branched alkyl;

R″ is C 1-7 straight-chain alkyl or C 3-7 branched alkyl;

with the proviso that when R 2 is

or

R 8 is not —CH 2 C 6 H 5 ;

with the proviso that when R 2 is —CH 2 C 6 H 5 , R 8 is lower cycloalkyl; and

with the proviso that when R 6 is NH 2 , R 2 is,

or C 2-5 straight chain alkyl;

or R 8 is not —CH 2 C 6 H 5 .

2. A compound according to claim 1 ,

wherein R 2 is

and

X is —O— or —S—.

3. A compound according to claim 1 , wherein R 2 is C 2-5 straight-chain alkyl.

4. A compound according to claim 1 , wherein R 8 is lower cycloalkyl or H.

5. A compound according to claim 1 , wherein R 8 is —CH 2 C 6 H 5 .

6. A compound according to claim 1 , wherein R 11 is —CH 2 OC(O)C(CH 3 ) 3 .

7. A compound according to claim 1 , wherein R″ is —C(CH 3 ) 3 , —CH(CH 3 ) 2 , —CH 2 C(CH 3 ) 3 , or —CH 2 CH(CH 3 ) 2 .

8. A kit comprising a compound according to claim 1 .

9. A method for detecting luminescence in a sample comprising contacting said sample with a compound according to claim 1 .

10. The method of claim 7 , wherein the sample contains live cells.

11. The method of claim 7 , wherein the sample contains a coelenterazine-utilizing luciferase.

12. A method for detecting luminescence in a transgenic animal comprising administering to said transgenic animal a compound according to claim 1 .

13. A compound of formula (Ia) or formula (Ib):

wherein R 2 is selected from the group consisting of

R 6 is selected from the group consisting of —H, —OH, —NH 2 , —OC(O)R or —OCH 2 OC(O)R;

R 8 is selected from the group consisting of —CH 2 C 6 H 5 , —C(R 3 )(R 4 )H, H or lower cycloalkyl;

wherein R 3 and R 4 are both H or both C 1-2 alkyl;

X is —NR 22 —;

Z is —CH— or —N—;

R 22 is CH 3 or CH 2 CH 3 ;

each R is independently C 1-7 straight-chain alkyl or C 3-7 branched alkyl;

each R 11 is independently —C(O)R″ or —CH 2 OC(O)R″; and

R″ is C 1-7 straight-chain alkyl or C 3-7 branched alkyl.

14. A compound according to claim 13 , wherein R 8 is —C(R 3 )(R 4 )H, lower cycloalkyl or H.

15. A compound according to claim 13 , wherein R 8 is —CH 2 C 6 H 5 .

16. A compound according to claim 13 , wherein R 11 is —CH 2 OC(O)C(CH 3 ) 3 .

17. A compound of formula (Ia) or formula (Ib):

wherein R 2 is selected from the group consisting of

or C 2-5 straight chain alkyl;

R 6 is selected from the group consisting of —H, —OH, —NH 2 , —OC(O)R or —OCH 2 OC(O)R;

R 8 is selected from the group consisting of —CH 2 C 6 H 5 , —C(R 3 )(R 4 )H, H or lower cycloalkyl;

wherein R 3 and R 4 are both H or both C 1-2 alkyl;

W is —NH 2 , halo, —OH, —NHC(O)R, —CO 2 R;

X is —S—, —O— or —NR 22 —;

Y is —H;

Z is —CH— or —N—;

each R 11 is independently —C(O)R″ or —CH 2 OC(O)R″;

R 22 is H;

each R is independently C 1-7 straight-chain alkyl or C 3-7 branched alkyl;

R″ is C 1-7 straight-chain alkyl or C 3-7 branched alkyl;

with the proviso that when R 2 is —CH 2 C 6 H 5 , R 8 is —C(R 3 )(R 4 )H or lower cycloalkyl; and

with the proviso that when R 6 is NH 2 , R 2 is,

or C 2-5 straight chain alkyl;

or R 8 is not —CH 2 C 6 H 5 .

18. A compound according to claim 17 ,

wherein R 2 is

and

X is —O— or —S—.

19. A compound according to claim 17 , wherein R 2 is C 2-5 straight-chain alkyl.

20. A compound according to claim 17 , wherein R 8 is —C(R 3 )(R 4 )H, lower cycloalkyl or H.

21. A compound according to claim 17 , wherein R 8 is —CH 2 C 6 H 5 .

22. A compound according to claim 17 , wherein R 11 is —CH 2 OC(O)C(CH 3 ) 3 .

23. A compound according to claim 17 , wherein R″ is —C(CH 3 ) 3 , —CH(CH 3 ) 2 , —CH 2 C(CH 3 ) 3 , or —CH 2 CH(CH 3 ) 2 .

24. A compound selected from

25. A compound of formula

26. A compound selected from:

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2012
From: KLAUBERT, DIETER H.; MEISENHEIMER, PONCHO; UNCH, JAMES
To: PROMEGA CORPORATION
Reel/Frame 027561/0939 →